Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome
A legfontosabb adatok
- Hol
- Ann Arbor, Atlanta, Boston, Chicago, Columbus, Covington, Indianapolis, Milwaukee, New York, Philadelphia, Phoenix, Portland, Rochester és St Louis (Egyesült Államok)Mind a 15 helyszín megnézése
Helyszínek itt: Egyesült Államok
- University of MichiganAnn Arbor, Egyesült ÁllamokNo longer taking part
- Emory University SchoolAtlanta, Egyesült ÁllamokNo longer taking part
- Massachusetts General HospitalBoston, Egyesült ÁllamokNo longer taking part
- Northwestern UniversityChicago, Egyesült ÁllamokNo longer taking part
- Endocrinology Research Associates, Inc.Columbus, Egyesült ÁllamokNo longer taking part
- St Elizabeth PhysiciansCovington, Egyesült ÁllamokNo longer taking part
- Indiana University Schl-medIndianapolis, Egyesült ÁllamokNo longer taking part
- Froedtert HospitalMilwaukee, Egyesült ÁllamokNo longer taking part
- Memorial Sloan-Kettering Cancer Center (Mskcc) - New YorkNew York, Egyesült ÁllamokNo longer taking part
- NYU Grossman School of MedicineNew York, Egyesült ÁllamokNo longer taking part
- University of Pennsylvania Medical CenterPhiladelphia, Egyesült ÁllamokNo longer taking part
- Barrow Neurological InstitutePhoenix, Egyesült ÁllamokNo longer taking part
- Oregon Health and Science UniversityPortland, Egyesült ÁllamokNo longer taking part
- Mayo Clinic - RochesterRochester, Egyesült ÁllamokNo longer taking part
- Washington University School of MedicineSt Louis, Egyesült ÁllamokNo longer taking part
A vizsgálat adatai
- Ki végzi
- RECORDATI GROUP
- Azonosító
- NCT05382156
- A regiszteradat frissítve
- 2025. november 20.
- Eredeti leírás
This is a non-interventional, multinational, multi-centre study with primary data collection, to further document the safety and efficacy of osilodrostat administered in routine clinical practice in patients treated with osilodrostat for endogenous Cushing's SyndromeA teljes eredeti leírásKevesebb
A Non-interventional Study to Assess the Long-term Safety and Efficacy of Osilodrostat in Patients With Endogenous Cushing's Syndrome
This is a non-interventional, multinational, multi-centre study with primary data collection, to further document the safety and efficacy of osilodrostat administered in routine clinical practice in patients treated with osilodrostat for endogenous Cushing's Syndrome
Bevonási feltételek: Written informed consent obtained prior to registration of any patient data; Male or female patients aged 18 years or older with endogenous CS treated with osilodrostat. Treatment with osilodrostat can either be initiated at the first visit of the study or can have been initiated before screening.
Kizáró feltételek: Patients participating in an interventional clinical trial with an investigational drug; Patients with exogenous CS; Patients with Pseudo CS.